Ads
related to: squamous cell carcinoma cancer
Search results
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 6 days agoAustin, TX, USA, May 21, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Non-Small-Cell Lung Cancer Drug Market ...
ASCO 2024: Merus touts positive Phase II data for head and neck cancer antibody
Pharmaceutical Technology via Yahoo Finance· 3 days agoThe abstracts were released after market closed on 23 May and shares in Merus rose by 15...describe...
Rutgers Cancer Institute and RWJBarnabas Health Set to Unveil Extensive, New Cancer Research...
FOX 4 Kansas City· 3 days agoClinicians and scientists from Rutgers Cancer Institute and RWJBarnabas Health will lead sessions...
Cancer Biotech Stocks Are on the Move Ahead of a Big Event. What to Know.
Barrons.com· 3 days agoThe American Society of Clinical Oncology is set to gather on May 31 in Chicago for its annual...
... in Combination with anti-PD-1 for First Line Recurrent and/or Metastatic Head and Neck Cancer to...
KPVI· 3 days agoThe data will be presented in a poster at the 2024 American Society of Clinical Oncology Annual Meeting (ASCO 2024) on June 2, 2024.
Regeneron (REGN) Announces Positive Data on Oncology Candidate
Zacks via Yahoo Finance· 3 days agoRegeneron's (REGN) REGN7075, in combination with its oncology drug Libtayo, generates anti-tumor...
Hammerling-Hodgers: Summer is here. Take protective measures to stay safe from sun's rays
Florida Today via Yahoo News· 6 days agoIf there is a mole that you are born with and changes or a new skin lesion appears and does not go...
Phio Pharmaceuticals Announces Presentation at the Annual Meeting of the American Society of...
Digital Journal· 3 days agoStages 1 and 2 cSCC represent 77% of all new cSCC...Cutaneous Carcinoma Poster Number: TPS9620 Topic: Melanoma/Skin Cancer Presenting Author: Mary Spellman ...
Study Finds Radiotherapy for NMSC in Dermatology Growing
Medscape· 6 days agoMore specifically, the persistent growth in the use of superficial radiotherapy (SRT) devices and...
OncoHost to Present Poster Demonstrating PROphet®'s Application in Multiple Cancer Indications at...
FOX21 Colorado Springs· 4 days agoThe presentation will highlight the ability of the company's PROphet® platform to predict clinical benefit from immune checkpoint inhibitor (ICI)-based therapies across various cancer ...